In cancers such as glioma, however, it remains unclear how exactly allergy and IgE may be protective and, as such, further research is urgently needed to understand the specific glioma microenvironment and its interactions with immune responses [53], before specific IgE immunotherapies could be developed. Here, IGHE is linked to central nervous system cancer.